Address: Insure Insights 61 Bridge Street, Kington.HR5 3DJ United Kingdom

Global Regenerative Medicine Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Home
  • Reports
  • Global Regenerative Medicine Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028
Global Regenerative Medicine Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

Global Regenerative Medicine Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Published Date: 30 Jun 2021
  • Report ID: HLT 00228
  • Pages: 181
  • Base Year: 2019
  • Format: PDF
  • Historical Data: 2016-2019

According to a study published by Insure Insights, the global regenerative medicine is estimated to grow at a CAGR of 25.8% during the forecast period. Regenerative medicine is the discipline of medicine used for the regeneration or replacement of organs, human cells, and tissues to re-established normal functionality. Regenerative medicine focus on renewing or replace cells in human tissues and organs that have been damaged and failed to function due to injury or illness. It is achieved by promoting the body’s cells to heal or treating a patient with laboratory-grown cells and tissues. It holds the ability to treat previously incurable chronic diseases and conditions, including spinal cord injuries, Alzheimer’s disease, Parkinson’s disease, diabetes, heart disease, renal failure, osteoporosis, and others. Besides, the entire organ can be generated for transplantation using regenerative medicine.

Top Driver: Revolution of Stem Cell Technology and Advancement in Monitoring Devices & Surgical Technologies

The factors driving the growth of this market, such as the revolution of stem cell technology, advancement in monitoring devices and surgical technologies, untapped potential of nanotechnology, increase in the prevalence of chronic diseases & trauma emergencies, rise in the incidence of degenerative diseases, and insufficient organs for transplantation. Growing focus on stem cells and growth in R&D activities in emerging economies is expected to propel the market growth. The developing countries are focused on technological advancements, which is estimated to boost market growth worldwide. On the other hand, stringent government norms, operational inefficiency, and high cost associated with treatment through regenerative medicine are estimated to hinder the growth of the market.

Genetically Derived Material Segment Market Accounts for the Largest Market Share

The market is segmented into synthetic material, biologically derived material, genetically engineered material, and pharmaceutical-based on the material. The biologically derived material is the dominant segment and is expected to maintain dominance during the forecast period. The demand for genetically engineered material has increased due to their distinctive properties such as increased proliferation, promotion of cellular interactions, control the manipulation of cellular behavior, and differentiation of cells that facilitate self-assembly into directionally organized structures.  The market has been segmented into cell therapy, gene therapy, tissue engineering, and small molecule & biologic. Based on the Application, the market is segmented into cardiovascular, oncology, dermatology, and others.

 Surging Research Activities in the Field of Regenerative Medicine to Benefit North America Market

The regenerative medicine market in North America is expected to hold the largest share globally, also grow at a significant rate during the forecast period. Growing awareness of personalized medicine, surging research activities in the field of regenerative medicine, and the introduction of CAR-T cell therapies have also resulted in the establishment of stem cell banking and tissue engineering, thereby boosting the market in the region. Following North America, the Asia Pacific is estimated to witness significant growth during the forecast period owing to the development of infrastructure and facilities to escalate stem cell research in the emerging regional economies.

Players to Focus on Mergers and Acquisition and Product Development

The global regenerative medicine is estimated to stay fragmented during the forecast period owing to the possible new entrants. The major players operating in the market are Zimmer Biomet, Stryker Corporation, Athersys, Medtronic, U.S. Stem Cell, Integra Lifesciences, Organogenesis, Acelity Holdings, CryoLife, and Isto Biologics.

SanBio Group: In September, 2019 the SanBio Group a scientific leader in regenerative medicine for neurological disorders, announced that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) Designation for SB623 cell therapy for the treatment of chronic neurological disorders.

Scope of the Report

By Product Type

  • Cell Therapy
  • Gene therapy
  • Tissue Engineering
  • Small Molecule & Biologic

By Application

  • Cardiovascular
  • Oncology
  • Dermatology
  • Others

By Material

  • Synthetic material
  • Biologically derived material
  • Genetically engineered material
  • Pharmaceutical

By Region

  • Europe
  • Asia Pacific
  • SAMEA

Key Reasons to Purchase this Report

  1. It provides a technological development map over time to understand the growth rate of the industry.
  2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
  3. It renders definite analysis for changing competitive dynamics.
  4. It builds a seven-year estimate based on how the market is predicted to grow.

Table of Content

Chapter 1           Overview And Scope

1.1             Market Vision

1.1.1          Market Definition

1.1.2          Market Scope

1.2             Market Segmentation

Chapter 2           Our Research Practice

2.1             Our Research Methodology

2.2             Data Triangulation

2.3             Data Sources

2.4             Assumptions for the study

2.5             Approach Adopted

Chapter 3           Executive Summary

3.1             Market Snapshot

3.2             Regional Snapshot

3.3             Segment Summary

Chapter 4           Covid-19 Impact Analysis

4.1             Overview

4.2             Prevalence analysis

4.3             Key Factor Impact Analysis

Chapter 5           Global Sepsis Diagnostic Market Forces

5.1             What’s Driving the Market

5.2             Porter’s Five Forces Analysis

5.2.1          Power of Suppliers

5.2.2          Threats From New Entrants

5.2.3          Power of Buyer

5.2.4          Threat From Substitute Product

5.2.5          Degree of Competition

Chapter 6           Global Sepsis Diagnostic Market -Industry Snapshots

6.1             Overview

6.1.1          Global Sepsis Diagnostic Market Value, 2019 – 2028, (US$ Bn)

6.2             Market Overview

6.2.1          Drivers Analysis

6.2.2          Restraint/Challenges analysis

6.2.3          Opportunity Analysis

6.3             Supply Chain/Value Chain Analysis

6.4             Market SWOT Analysis

Chapter 7           Global Sepsis Diagnostic Market Analysis, by Technology

7.1             Overview

7.2             Key Findings for Sepsis Diagnostic Market- By Technology

7.2.1          Sepsis Diagnostic Market- Molecular diagnostic

7.2.2          Sepsis Diagnostic Market- Immunoassay

7.2.3          Sepsis Diagnostic Market- Microbiology

7.2.4          Sepsis Diagnostic Market- Others

Chapter 8           Global Sepsis Diagnostic Market Analysis, by Product

8.1             Overview

8.2             Key Findings for Sepsis Diagnostic Market- By Product

8.2.1          Sepsis Diagnostic Market- Instruments

8.2.2          Sepsis Diagnostic Market- Assay kits

8.2.3          Sepsis Diagnostic Market- Blood culture media

8.2.4          Sepsis Diagnostic Market- Others

Chapter 9           Global Sepsis Diagnostic Market Analysis, by Diagnostic method

9.1             Overview

9.2             Key Findings for Sepsis Diagnostic Market- By Diagnostic method

9.2.1          Sepsis Diagnostic Market- Laboratory testing

9.2.2          Sepsis Diagnostic Market- PoC testing

Chapter 10       Global Sepsis Diagnostic Market Analysis, by Pathogen

10.1           Overview

10.2           Key Findings for Sepsis Diagnostic Market- By Pathogen

10.2.1       Sepsis Diagnostic Market- Fungal sepsis

10.2.2       Sepsis Diagnostic Market- Bacterial sepsis

10.2.3       Sepsis Diagnostic Market- Others

Chapter 11       Sepsis Diagnostic Market Analysis by Region

11.1           Key Findings for Sepsis Diagnostic Market- By region

11.2           Overview

11.2.1       Global Sepsis Diagnostic Market Analysis, By Technology, 2019 – 2028

11.2.2       Global Sepsis Diagnostic Market Analysis, By Product, 2019 – 2028

11.2.3       Global Sepsis Diagnostic Market Analysis, By Diagnostic method, 2019 – 2028

11.2.4       Global Sepsis Diagnostic Market Analysis, By Pathogen, 2019 – 2028

11.3           Sepsis Diagnostic Market – North America

11.3.1       Overview

11.3.2       U.S.

11.3.3       Canada

11.3.4       Mexico

11.3.5       North America Market, By Technology

11.3.6       North America Market, By Product

11.3.7       North America Market, By Diagnostic method

11.3.8       North America Market, By Pathogen

11.4           Sepsis Diagnostic Market – Europe

11.4.1       Overview

11.4.2       Germany

11.4.3       United Kingdom

11.4.4       France

11.4.5       Italy

11.4.6       Rest Of Europe

11.4.7       Europe Market, By Technology

11.4.8       Europe Market, By Product

11.4.9       Europe market by, Diagnostic method

11.4.10     Europe Market, By Pathogen

11.5           Sepsis Diagnostic Market – Asia Pacific

11.5.1       Overview

11.5.2       China

11.5.3       Japan

11.5.4       India

11.5.5       Rest of APAC

11.5.6       Asia Pacific Market, By Technology

11.5.7       Asia Pacific Market, By Product

11.5.8       Asia Pacific Market, By Diagnostic method

11.5.9       Asia Pacific Market, By Pathogen

11.6           Sepsis Diagnostic Market – SAMEA

11.6.1       Overview

11.6.2       Middle East & Africa (MEA)

11.6.3       South America

11.6.4       Rest Of World

11.6.5       South America, Middle East and Africa Market, By Technology

11.6.6       South America, Middle East and Africa Market, By Product

11.6.7       South America, Middle East and Africa Market, By Diagnostic method

11.6.8       South America, Middle East and Africa Market, By Pathogen

Chapter 12       Market Competition Analysis

12.1           Market Share/Positioning Analysis

12.1.1       Market Positioning of Key Vendors, 2019

12.1.2       Key Strategies Adopted by the Leading Players

12.1.3       Recent Developments

Chapter 13       Company Profiles- Snapshot

13.1           bioMérieux SA

13.1.1       Business Fundamentals

13.1.2       Financial Snapshots

13.1.3       Product Portfolio

13.1.4       Recent Developments

13.2           Beckman Coulter, Inc.

13.3           Becton, Dickinson and Company

13.4           Sysmex Corporation

13.5           F. Hoffmann-La Roche AG

13.6           Thermo Fisher Scientific, Inc.

*More than 10 Companies are profiled in this Research Report*

*Financials would be provided on a best efforts basis for private companies”

Chapter 14       Appendix

 

 

 

Request for Sample

Please fill out the form to receive sample pages of the report